ESSENTIAL HYPERTENSION - EFFECT OF AN ORAL INHIBITOR OF ANGIOTENSIN-CONVERTING ENZYME

被引：77
|
作者：
MACGREGOR, GA
MARKANDU, ND
ROULSTON, JE
JONES, JC
机构：
来源：
BRITISH MEDICAL JOURNAL | 1979年 / 2卷 / 6198期
关键词：
D O I：
10.1136/bmj.2.6198.1106
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页码：1106 / 1109
页数：4
相关论文
共 50 条
  • [31] ANTIHYPERTENSIVE AND HORMONAL EFFECTS OF THE NEW ORAL ANGIOTENSIN-CONVERTING ENZYME-INHIBITOR DELAPRIL (CV-3317) IN ESSENTIAL-HYPERTENSION
    MIZUNO, K
    YATABE, Y
    YABE, R
    TANI, M
    NIIMURA, S
    SUENAGA, K
    FUKUCHI, S
    CURRENT THERAPEUTIC RESEARCH-CLINICAL AND EXPERIMENTAL, 1989, 45 (02): : 305 - 315
  • [32] EFFECT OF THE ANGIOTENSIN-CONVERTING ENZYME-INHIBITOR, CAPTOPRIL, ON DEVELOPMENT OF RENAL-HYPERTENSION IN RATS
    FREGLY, MJ
    LOCKLEY, OE
    SIMPSON, CE
    PHARMACOLOGY, 1981, 22 (05) : 277 - 285
  • [33] Renal angiotensin-converting enzyme and angiotensin-converting enzyme 2 gender differences in fetal programmed hypertension
    Stone, Ryan
    Su, Yixin
    Rose, James C.
    AMERICAN JOURNAL OF OBSTETRICS AND GYNECOLOGY, 2011, 204 : S207 - S208
  • [34] Alterations in Circulatory and Renal Angiotensin-Converting Enzyme and Angiotensin-Converting Enzyme 2 in Fetal Programmed Hypertension
    Shaltout, Hossam A.
    Figueroa, Jorge P.
    Rose, James C.
    Diz, Debra I.
    Chappell, Mark C.
    HYPERTENSION, 2009, 53 (02) : 404 - 408
  • [35] ANGIOTENSIN-CONVERTING ENZYME-INHIBITION, CATECHOLAMINES AND HEMODYNAMICS IN ESSENTIAL-HYPERTENSION
    MUIESAN, G
    ALICANDRI, CL
    AGABITIROSEI, E
    FARIELLO, R
    BESCHI, M
    BONI, E
    CASTELLANO, M
    MONITI, E
    MUIESAN, L
    ROMANELLI, G
    ZANIELLI, A
    AMERICAN JOURNAL OF CARDIOLOGY, 1982, 49 (06): : 1420 - 1424
  • [36] Expression of angiotensin-converting enzyme gene in whole blood in patients with essential hypertension
    Chandra, Sudhir
    Narang, Rajiv
    Saluja, Daman
    Bhatia, Jagriti
    Srivastava, Kamna
    BIOMARKERS, 2014, 19 (04) : 314 - 318
  • [37] Combined inhibition of neutral endopeptidase and angiotensin-converting enzyme by sampatrilat in essential hypertension
    Wallis, EJ
    Ramsay, LE
    Hettiarachchi, J
    CLINICAL PHARMACOLOGY & THERAPEUTICS, 1998, 64 (04) : 439 - 449
  • [38] Effects of Angiotensin-Converting Enzyme Inhibition on Leptin and Adiponectin Levels in Essential Hypertension
    Fontana, Vanessa
    Cabral de Faria, Ana Paula
    Oliveira-Paula, Gustavo Henrique
    Silva, Pamela Souza
    Biagi, Celso
    Tanus-Santos, Jose Eduardo
    Moreno, Heitor
    BASIC & CLINICAL PHARMACOLOGY & TOXICOLOGY, 2014, 114 (06) : 472 - 475
  • [39] Relationship of angiotensin-converting enzyme gene to essential hypertension and drug treatment in Chongqing
    Liu, Qing
    Lei, Han
    Wang, Xi
    Zhonghua Yixue Yichuanxue Zazhi/Chinese Journal of Medical Genetics, 2000, 17 (05): : 340 - 342
  • [40] INHIBITOR BINDING ASSAY FOR ANGIOTENSIN-CONVERTING ENZYME
    FYHRQUIST, F
    TIKKANEN, I
    GRONHAGENRISKA, C
    HORTLING, L
    HICHENS, M
    CLINICAL CHEMISTRY, 1984, 30 (05) : 696 - 700
12345